Location History:
- Boston, MA (US) (2021)
- Chestnut Hill, MA (US) (2021 - 2024)
Company Filing History:
3 out of 378 
3 out of 443 
3 out of 1,209 
Years Active: 2021-2024
Title: Inventor Spotlight: Monica Schenone
Introduction
Monica Schenone is a distinguished inventor based in Boston, MA, known for her significant contributions to the field of cancer research and treatment. With a total of three patents to her name, she has dedicated her career to developing innovative methods for patient stratification and enhancing cancer treatment protocols.
Latest Patents
Among her latest patents, Monica has introduced groundbreaking compounds and compositions aimed at cancer treatment. One notable invention focuses on compounds, compositions, and methods for cancer patient stratification and treatment. This patent highlights improved methods for identifying cancer patients through biomarkers such as PDE3A, SLFN12, and CREB3L1 that correlate with drug sensitivity. This innovative approach not only identifies patients effectively but also ensures that they receive targeted treatments using the specified agents.
Another significant patent from Monica includes compositions and methods for treating cancers that express PDE3A or SLFN12. This invention is particularly relevant for patients with melanoma, adenocarcinoma, lung, cervical, liver, or breast cancer. By utilizing the identified biomarkers, Monica’s work helps in creating a stratified patient population that can be treated more efficiently with agents like DNMDP, zardaverine, and anagrelide.
Career Highlights
Monica Schenone has worked with prestigious organizations throughout her career, notably Bayer Pharma Aktiengesellschaft and The Broad Institute, Inc. Her experience in these companies has allowed her to refine her expertise in cancer research and contribute to groundbreaking discoveries in the field.
Collaborations
Throughout her career, Monica has collaborated with esteemed colleagues, including Alex Burgin and Xiaoyun Wu. These partnerships have facilitated the exchange of ideas and the development of innovative strategies in cancer treatment.
Conclusion
In summary, Monica Schenone is a remarkable inventor who is making significant strides in the fight against cancer through her inventive contributions. Her patents not only promise to enhance patient care but also reflect her commitment to improving treatment outcomes for cancer patients, solidifying her place as a notable figure in the realm of medical innovation.